Forums » News and Announcements

investigational compound Cx601 (darvadstro

    • 244 posts
    October 25, 2019 3:50 PM HKT

    Anal Fistula Treatment Market is Registering a Healthy 4% CAGR between 2016 and 2026

    by poojam · September 4 Cheap Andrew Cogliano Shirt , 2018

    Transparency Market Research (TMR) has published a new report titled, 鈥?em>Anal Fistula Treatment Market 鈥?Global Industry Analysis, Size, Share, Growth Cheap Cam Fowler Shirt , Trends, and Forecast, 2018鈥?026鈥? According to the report, the global anal fistula treatment market was valued at US$ 550 Mn in 2017 and is projected to expand at a CAGR of 4.0% from 2018 to 2026. Rise in incidence of inflammatory bowel diseases is anticipated to propel demand for therapies used in the management of these diseases from 2018 to 2026.

    Increase in the number of cases of inflammatory bowel diseases (IBD) such as Crohn鈥檚 disease and ulcerative colitis across the world is a significant economic burden on the health care systems in several countries. Around 0.3% people in the industrialized countries have IBD. A report published in the Crohn鈥檚 & Colitis Foundation of America (CCFA) stated that nearly 1.6 million people in the U.S were affected with IBD in 2014, with 70 Cheap Corey Perry Shirt ,000 new cases reported each year.

    Of the total number of people with IBD in the U.S., 780,000 people had Crohn鈥檚 disease, while 907,000 had ulcerative colitis. The number of new cases reported is expected to rise in developing countries as compared to developed countries owing to western dietary patterns Cheap Rickard Rakell Jersey , increase in use of antibiotics, surge in exposure to pollution, and improvement in hygiene. Countries such as Japan, India, and China witnessed significant increase in the incidence of these conditions. Increase in the patient population is expected to drive demand for surgical as well as non-surgical interventions for the treatment of anal fistula. This in turn is likely to boost the growth of the market during the forecast period.

    Request for Sample Copy of Report @聽 ;rep_id=36980

    Ongoing efforts by major biopharmaceutical and medical device companies to launch novel products and therapies for the treatment of anal fistulae in patients are the other factors contributing to the growth of the market. Companies are increasingly adopting non-surgical methods for the treatment of anal fistula due to the significant benefits these offer. Non-surgical methods such as fibrin glue injection Cheap Antoine Vermette Jersey , adipose-derived stem cells therapy, and collagen paste involve usage of sphincter-conserving treatment techniques that help treat fecal incontinence caused due to surgical methods and have reduced recurrence rate in the treatment of complex anal fistulae.

    In December 2017, TiGenix NV and Takeda Pharmaceutical Company Limited announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) provided a positive opinion recommending the marketing authorization for its investigational compound Cx601 (darvadstrocel). Recommendation from regulatory agencies paves the way for introduction of the novel and minimally inva y, biolitec AG, Cook Medical, Gem srl, KARL STORZ SE & Co. KG Cheap Jakob Silfverberg Jersey , Medtronic, and No figure in . Wholesale Air Jordan   Wholesale Max Shoes   Cheap Nike Shoes Shop   Wholesale Nike Shoes   Cheap Jordan 11   Cheap Nike Shoes Online   Cheap Air Max Womens   Cheap Air Max Online   Cheap Nike Air Max 90   Cheap Air Max 270 Mens